Latest S-1 registration statements

Legence Corp., a leading provider of engineering, installation, and maintenance services for mission-critical building systems, has filed an S-1/A registration statement for its initial public offering of 26 million Class A Common Stock shares.

Gemini Space Station, Inc. is preparing for its initial public offering on the Nasdaq Global Select Market under the symbol GEMI, offering 16,666,667 shares of Class A common stock at an estimated price between $17.00 and $19.00 per share.

Miluna Acquisition Corp, a newly formed blank check company, has filed an S-1 registration statement for an initial public offering of 6 million units at $10.00 each, aiming to raise $60 million for a business combination.

Turn Therapeutics Inc., a pharmaceutical and medical device development company, files an S-1 registration statement for a direct listing on Nasdaq, focusing on its proprietary PermaFusion platform for dermatology and vaccine programs.

SpringBig Holdings, Inc. filed an S-1 to register the resale of over 90 million shares and warrants, signaling significant potential dilution and ongoing financial challenges.

Newbridge Acquisition Limited files S-1 for a $50 million initial public offering of units to pursue a business combination, focusing on high-growth sectors in emerging markets.

Elauwit Connection, a broadband network provider for multifamily and student housing, files for an initial public offering to raise $15 million, aiming to fund growth despite a history of losses and a going concern qualification.

BTC Development Corp. filed an S-1/A, an exhibits-only amendment, detailing offering expenses, private placement commitments, and trust account mechanics for its upcoming initial public offering.

Phoenix Education Partners, parent company of University of Phoenix, files S-1 for initial public offering, highlighting strong financial performance and student outcome improvements post-2017 transformation.

Bitwise Investment Advisers files an amended S-1 for its Solana ETF, outlining investment objectives, staking strategy, and extensive risk factors for investors.

Aptera Motors Corp. filed an amendment to its S-1 registration statement, primarily to update an exhibit, while its independent auditor noted substantial doubt about the company's ability to continue as a going concern.

Grayscale Investments Sponsors, LLC has filed an S-1 registration statement for a spot Polkadot Trust ETF, aiming to provide investors exposure to DOT while navigating regulatory hurdles and potential staking opportunities.

Grayscale Investments Sponsors, LLC has filed an S-1 registration statement for its Grayscale Cardano Trust ETF, seeking to list Shares on NYSE Arca to provide investors with exposure to ADA.

Rice Acquisition Corporation 3, a new blank check company, is launching a $250 million initial public offering to target businesses in the energy value chain, leveraging its management's extensive industry experience.

Farlong Holding Corporation, a science-driven healthcare and wellness company, has filed an S-1 registration statement for its initial public offering, seeking capital to fund operations and growth despite recurring losses and a going concern warning.

Super League Enterprise, Inc. converted its S-3 registration to an S-1 to register shares for a $20 million equity purchase agreement, signaling significant potential dilution and ongoing capital needs.

Akari Therapeutics has entered into an agreement with White Lion Capital for an equity line of up to $25 million, providing discretionary capital access over the next three years.

Azitra, an early-stage biopharmaceutical company, announced a best-efforts public offering of common stock and pre-funded warrants to raise up to $10 million for its precision dermatology programs, following a recent 1-for-6.66 reverse stock split and a 'going concern' warning.

NUBURU, Inc. has filed an S-1 registration statement for the resale of up to 30 million shares of common stock by a selling stockholder, as the company navigates significant financial losses, a going concern warning, and a strategic pivot.

Nuburu, Inc. filed an S-1 registration statement for the resale of up to 25,938,157 shares of common stock by various selling stockholders, including major convertible note holders.

Profusa, Inc. filed an S-1 registration statement for the resale of up to 222 million shares by Ascent Partners Fund LLC, following its July 2025 business combination, while disclosing ongoing financial losses and going concern doubts.

VisionWave Holdings, Inc. has finalized a $50 million Standby Equity Purchase Agreement and a $5 million pre-paid advance, bolstering its financial position as it progresses with AI-driven defense technology commercialization and strategic global pilot programs.

Chenghe Acquisition III Co., a blank check company, filed an S-1/A for its $110 million initial public offering, focusing on Asian market acquisitions despite significant dilution risks and China-related regulatory uncertainties.

BM Acquisition Corp., a Cayman Islands SPAC, filed an S-1/A for its $60 million initial public offering, targeting business combinations in Southeast Asia.

Grayscale Solana Trust (SOL) files an S-1/A amendment detailing its intent to list as an ETF on NYSE Arca, outlining cash-only creation/redemption, and future staking plans contingent on regulatory approval.

HeartCore Enterprises, Inc. filed an S-1/A to register the resale of up to 24 million shares by a selling stockholder and detail a $25 million equity purchase agreement, while also addressing Nasdaq listing compliance issues.

TruGolf Holdings, Inc. filed an S-1/A registration statement for the resale of up to 2,777,500 shares of Class A Common Stock by selling securityholders, following a reverse stock split and ongoing efforts to address Nasdaq listing deficiencies.

GoPro, Inc. filed an S-1 registration statement for the resale of warrants and underlying common stock issued to Mateo Financing, LLC in connection with a new $50 million credit agreement.

BioAffinity Technologies files S-1 to register 12.6 million shares for resale by investors, following recent private placements and facing potential Nasdaq delisting due to bid price and equity deficiencies.

BridgeBio Oncology Therapeutics, Inc. (BBOT) filed an S-1 registration statement detailing its recent SPAC merger, PIPE financing, and clinical-stage oncology pipeline targeting RAS and PI3K-driven cancers.